CALABASAS, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc . (Nasdaq: KYTH ) today announced that Keith Leonard, president and chief executive officer, will present at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas.
| Event: Bank of America Merrill Lynch 2014 Health Care Conference |
| Date: Wednesday, May 14, 2014 |
| Time: 10:40 a.m. PT |
A live webcast will be available under the Investors section of the Company's website at www.kytherabiopharma.com . The presentation will be archived on the website and will be available for at least 14 days.
About KYTHERA Biopharmaceuticals, Inc.
KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is currently in late stage clinical trials for the reduction of submental fat, which commonly presents as a double chin, and is a potential first-in-class submental contouring injectable drug. KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring.
Investor Contact: Heather Rowe Associate Director, Investor Relations Tel: (818) 587- 4559